GABAA receptor interactions with propofol

Binding site location and conformational changes

Myles Akabas, Moez Bali

Research output: Contribution to journalArticle

Abstract

The GABAA receptor is a major target of the intravenous anesthetic propofol. In order to obtain an understanding of propofol's actions at a molecular level we have attempted to identify the propofol binding site and the conformational changes that propofol binding induces. Using changes in the reactivity of cysteines substituted in the M3 membrane-spanning segment we show that propofol stabilizes a receptor conformational state that is distinct from the states stabilized by GABA and by diazepam. Separately, we have used propofol's ability to protect engineered cysteines from modification by the sulfhydryl-reactive reagent, pCMBS-, to identify propofol binding site residues. β2Met286, near the M3 extracellular end, is protected but the aligned residue α1Ala291 and the M2 15′ residues are not. We infer that β2Met286 is part of a propofol binding site. These studies are beginning to provide a molecular level description of general anesthetic action on GABAA receptors.

Original languageEnglish (US)
Pages (from-to)3-8
Number of pages6
JournalInternational Congress Series
Volume1283
DOIs
StatePublished - Nov 2005

Fingerprint

Propofol
GABA-A Receptors
Binding Sites
Cysteine
Intravenous Anesthetics
Sulfhydryl Reagents
General Anesthetics
Diazepam
gamma-Aminobutyric Acid
Membranes

Keywords

  • Acetylcholine
  • Anesthesia
  • Benzodiazepine
  • Cysteine
  • Glycine
  • Ion channel
  • Propofol

ASJC Scopus subject areas

  • Medicine(all)

Cite this

GABAA receptor interactions with propofol : Binding site location and conformational changes. / Akabas, Myles; Bali, Moez.

In: International Congress Series, Vol. 1283, 11.2005, p. 3-8.

Research output: Contribution to journalArticle

@article{92f5344dfc96498ea9065fd31faeea2c,
title = "GABAA receptor interactions with propofol: Binding site location and conformational changes",
abstract = "The GABAA receptor is a major target of the intravenous anesthetic propofol. In order to obtain an understanding of propofol's actions at a molecular level we have attempted to identify the propofol binding site and the conformational changes that propofol binding induces. Using changes in the reactivity of cysteines substituted in the M3 membrane-spanning segment we show that propofol stabilizes a receptor conformational state that is distinct from the states stabilized by GABA and by diazepam. Separately, we have used propofol's ability to protect engineered cysteines from modification by the sulfhydryl-reactive reagent, pCMBS-, to identify propofol binding site residues. β2Met286, near the M3 extracellular end, is protected but the aligned residue α1Ala291 and the M2 15′ residues are not. We infer that β2Met286 is part of a propofol binding site. These studies are beginning to provide a molecular level description of general anesthetic action on GABAA receptors.",
keywords = "Acetylcholine, Anesthesia, Benzodiazepine, Cysteine, Glycine, Ion channel, Propofol",
author = "Myles Akabas and Moez Bali",
year = "2005",
month = "11",
doi = "10.1016/j.ics.2005.07.014",
language = "English (US)",
volume = "1283",
pages = "3--8",
journal = "International Congress Series",
issn = "0531-5131",

}

TY - JOUR

T1 - GABAA receptor interactions with propofol

T2 - Binding site location and conformational changes

AU - Akabas, Myles

AU - Bali, Moez

PY - 2005/11

Y1 - 2005/11

N2 - The GABAA receptor is a major target of the intravenous anesthetic propofol. In order to obtain an understanding of propofol's actions at a molecular level we have attempted to identify the propofol binding site and the conformational changes that propofol binding induces. Using changes in the reactivity of cysteines substituted in the M3 membrane-spanning segment we show that propofol stabilizes a receptor conformational state that is distinct from the states stabilized by GABA and by diazepam. Separately, we have used propofol's ability to protect engineered cysteines from modification by the sulfhydryl-reactive reagent, pCMBS-, to identify propofol binding site residues. β2Met286, near the M3 extracellular end, is protected but the aligned residue α1Ala291 and the M2 15′ residues are not. We infer that β2Met286 is part of a propofol binding site. These studies are beginning to provide a molecular level description of general anesthetic action on GABAA receptors.

AB - The GABAA receptor is a major target of the intravenous anesthetic propofol. In order to obtain an understanding of propofol's actions at a molecular level we have attempted to identify the propofol binding site and the conformational changes that propofol binding induces. Using changes in the reactivity of cysteines substituted in the M3 membrane-spanning segment we show that propofol stabilizes a receptor conformational state that is distinct from the states stabilized by GABA and by diazepam. Separately, we have used propofol's ability to protect engineered cysteines from modification by the sulfhydryl-reactive reagent, pCMBS-, to identify propofol binding site residues. β2Met286, near the M3 extracellular end, is protected but the aligned residue α1Ala291 and the M2 15′ residues are not. We infer that β2Met286 is part of a propofol binding site. These studies are beginning to provide a molecular level description of general anesthetic action on GABAA receptors.

KW - Acetylcholine

KW - Anesthesia

KW - Benzodiazepine

KW - Cysteine

KW - Glycine

KW - Ion channel

KW - Propofol

UR - http://www.scopus.com/inward/record.url?scp=33646443238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646443238&partnerID=8YFLogxK

U2 - 10.1016/j.ics.2005.07.014

DO - 10.1016/j.ics.2005.07.014

M3 - Article

VL - 1283

SP - 3

EP - 8

JO - International Congress Series

JF - International Congress Series

SN - 0531-5131

ER -